Skip to main content

Find Clinical Trials

Home
Conditions
Renal Cell Carcinoma

Clinical trial condition

Renal Cell Carcinoma

Explore clinical trials studying Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.

412 public trials 75 recruiting studies

Refine in advanced search Browse all conditions

Renal Cell Carcinoma trial results

Completed

A Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma

NCT01865747

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Birmingham, Alabama, United States

Anchorage, Alaska, United States

Gilbert, Arizona, United States

Scottsdale, Arizona, United States

View all 205 locations

View Trial Details

Completed

Prospective Patient Reported Outcomes (PRO) Registry in Patients With Advanced Renal Cell Carcinoma

NCT02537743

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Multiple sites all over Germany Multiple Locations, Germany

View Trial Details

Completed

Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma

NCT00258687

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +29 more
Locations: Children's Hospital Boston Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma

NCT00827359

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England

NCT04637204

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Ipsen Facility Slough, United Kingdom

View Trial Details

Completed

Imaging Correlates of Renal Cell Carcinoma Biological Features

NCT01665703

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States

View Trial Details

Completed

Case-Control Study of Renal Cell Cancer Among Caucasions and African Americans in the United States

NCT00340457

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: University of Illinois at Chicago Chicago, Illinois, United States

Wayne State University Detroit, Michigan, United States

View Trial Details

Completed

A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer

NCT02082210

Conditions: Adenocarcinoma, Advanced Cancer, Bronchial Neoplasms, +31 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Memorial Sloan Kettering Cancer Center New York, United States

Tennessee Oncology PLLC Nashville, Tennessee, United States

View Trial Details

Completed

A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus

NCT01798446

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: Seou National University Hospital Seoul, South Korea

View Trial Details

Completed

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

NCT01297244

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Southern Cancer Center Mobile, Alabama, United States

Providence Health and Services Burbank, California, United States

David Geffen School of Medicine at UCLA Los Angeles, California, United States

Rocky Mountain Cancer Center Denver, Colorado, United States

View all 25 locations

View Trial Details